NO994463L - Antitumor activity enhancement method of unprocessed natural remedies, composition containing unprocessed herbal enhancement antitumor activity, evaluation of method of antitumor efficacy in treatment with unprocessed herbal medicine - Google Patents

Antitumor activity enhancement method of unprocessed natural remedies, composition containing unprocessed herbal enhancement antitumor activity, evaluation of method of antitumor efficacy in treatment with unprocessed herbal medicine

Info

Publication number
NO994463L
NO994463L NO994463A NO994463A NO994463L NO 994463 L NO994463 L NO 994463L NO 994463 A NO994463 A NO 994463A NO 994463 A NO994463 A NO 994463A NO 994463 L NO994463 L NO 994463L
Authority
NO
Norway
Prior art keywords
unprocessed
enhancement
antitumor
antitumor activity
herbal
Prior art date
Application number
NO994463A
Other languages
Norwegian (no)
Other versions
NO994463D0 (en
Inventor
Niwa Kozo
Original Assignee
Niwa Kozo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Niwa Kozo filed Critical Niwa Kozo
Publication of NO994463D0 publication Critical patent/NO994463D0/en
Publication of NO994463L publication Critical patent/NO994463L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/07—Basidiomycota, e.g. Cryptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0004—Homeopathy; Vitalisation; Resonance; Dynamisation, e.g. esoteric applications; Oxygenation of blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/10—Preparation or pretreatment of starting material

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Hematology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Urology & Nephrology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Endocrinology (AREA)
  • Pathology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Denne oppfinnelsen vedrører en fremgangsmåte for å forsterke en antitumoraktivitet ved steking av en sopp med lange infrarøde stråler som inneholder B-glukan, deretter utføres en fermentering ved å tilsette "Koji" og ytterligere fremstille et oljemiddel. Oppfinnel- sen vedrører også en sammensetning som inneholder et uforedlet naturlegemiddel hvor en slik metode blir anvendt, og en metode for å evaluere og forvente at antitumoraktivi- teten på tidspunktet for den innvortes administrering er større når en øker ratioen av den dannede mengden av et lipidperoksyd, og en metode for evaluering av antitumoreffek- tivileten for behandlingen anvendt på det uforedlede naturlegemidlet ved å bruke de nevnte metodene.This invention relates to a method of enhancing anti-tumor activity by roasting a long-infrared fungus containing B-glucan, then a fermentation is performed by adding "Koji" and further preparing an oil agent. The invention also relates to a composition containing an unprocessed herbal drug in which such a method is used, and a method for evaluating and expecting antitumor activity at the time of internal administration to be greater when increasing the ratio of the amount of lipid peroxide produced. , and a method for evaluating the antitumor efficacy efficacy of the treatment applied to the unprocessed natural remedy using the methods mentioned.

NO994463A 1998-09-17 1999-09-15 Antitumor activity enhancement method of unprocessed natural remedies, composition containing unprocessed herbal enhancement antitumor activity, evaluation of method of antitumor efficacy in treatment with unprocessed herbal medicine NO994463L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP26375398 1998-09-17
JP10323374A JP2000159682A (en) 1998-09-17 1998-11-13 Method of strengthening antitumor activity of crude drug, composition containing crude drug for strengthening antitumor activity, method of evaluating antitumor effectivity treated by crude drug and method of evaluating antitumor effectivity of crud drug

Publications (2)

Publication Number Publication Date
NO994463D0 NO994463D0 (en) 1999-09-15
NO994463L true NO994463L (en) 2000-03-20

Family

ID=26546176

Family Applications (1)

Application Number Title Priority Date Filing Date
NO994463A NO994463L (en) 1998-09-17 1999-09-15 Antitumor activity enhancement method of unprocessed natural remedies, composition containing unprocessed herbal enhancement antitumor activity, evaluation of method of antitumor efficacy in treatment with unprocessed herbal medicine

Country Status (19)

Country Link
JP (1) JP2000159682A (en)
KR (1) KR20000023206A (en)
CN (1) CN1255376A (en)
AU (1) AU4486299A (en)
BE (1) BE1012725A5 (en)
CA (1) CA2282234A1 (en)
DE (1) DE19944695A1 (en)
DK (1) DK199901235A (en)
ES (1) ES2155802B1 (en)
FR (2) FR2783426A1 (en)
GB (2) GB9920710D0 (en)
ID (1) ID23150A (en)
IL (1) IL131722A0 (en)
IS (1) IS5183A (en)
IT (1) IT1307267B1 (en)
NL (2) NL1013049C2 (en)
NO (1) NO994463L (en)
SE (2) SE9903307L (en)
SG (1) SG76631A1 (en)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100391439C (en) * 2001-04-27 2008-06-04 味之素株式会社 Immunopotentiators
WO2002090559A1 (en) * 2001-05-07 2002-11-14 Biohub Co., Ltd. A method for preparing lactic acid fermented solution of mushroom and lactic acid fermented solution of mushroom produced thereby
JP4499979B2 (en) * 2001-05-21 2010-07-14 コンビ株式会社 Composition for controlling pathogen infection
EP1393738A4 (en) * 2001-06-01 2004-11-17 Ajinomoto Kk Drugs for diabetes
JP4681801B2 (en) * 2002-05-15 2011-05-11 ビーエイチエヌ株式会社 Angiogenesis inhibitor and method for producing the same
JP4826696B2 (en) * 2003-04-07 2011-11-30 ビーエイチエヌ株式会社 Angiogenesis inhibitors
TWI330533B (en) 2002-05-15 2010-09-21 Bhn Co Ltd Composition for angiogenesis inhibition, neoplasm inhibition,or immunostimulation
JP2005089417A (en) * 2003-09-19 2005-04-07 Noevir Co Ltd Composition for prevention/treatment of diabetes
JP4587441B2 (en) * 2004-02-12 2010-11-24 株式会社クレハ Novel diabetes treatment and food
WO2006030750A1 (en) 2004-09-17 2006-03-23 Ssi Co., Ltd. Extract from agaricus blazei murrill capable of inhibiting breast cancer
JP2006273835A (en) * 2005-03-04 2006-10-12 Michishi Tani Therapeutic agent for malignant tumor and food or beverage containing the same
WO2011014729A1 (en) * 2009-07-31 2011-02-03 Yukiguni Maitake Co., Ltd. Maitake mushroom coffee
WO2011081024A1 (en) * 2009-12-29 2011-07-07 株式会社富士見養蜂園 Umami food, and method for producing same
CN106333969A (en) * 2016-08-30 2017-01-18 青海民族大学 Agaricus gennadii HDAC1 enzyme inhibition effective part and preparation method and application
CN106309511A (en) * 2016-08-30 2017-01-11 青海民族大学 Effective part of agaricus gennadii for inhibiting CDC25 enzyme as well as preparation method and application of effective part
US20200397817A1 (en) * 2017-11-30 2020-12-24 SHIEH, Darbin Method for predicting and modulating susceptibility of cancer cell to programmed cell death
KR102602787B1 (en) * 2020-12-16 2023-11-17 대한민국 Method for increasing the content of physiologically active ingredients and nutrients in Sparassis crispa
KR102646421B1 (en) * 2020-12-16 2024-03-12 대한민국 Method for increasing the content of physiologically active ingredients and nutrients in Grifola frondosa
KR102584680B1 (en) * 2020-12-17 2023-10-06 대한민국 Method for manufacturing tea of Lentinula edodes tea improved physiological activities and nutrition components

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5276413A (en) * 1975-12-18 1977-06-27 Kureha Chem Ind Co Ltd Production of oncostatic substances
US4177108A (en) * 1977-03-02 1979-12-04 Tetsuro Ikekawa Process for producing emitanin
DE2842691A1 (en) * 1978-09-30 1980-04-10 Karl Dr Med Theurer Activation of pharmaceuticals by irradiation - using wavelengths corresp. to absorption maxima of the substance, opt. with the simultaneous application of magnetic field
JPS57206618A (en) * 1981-06-12 1982-12-18 Noda Shiyokukin Kogyo Kk Preparation of antitumor substance
JPH02203765A (en) * 1989-02-02 1990-08-13 Nippon Beet Sugar Mfg Co Ltd Food having antitumor function and production thereof
JP3357383B2 (en) * 1991-08-14 2002-12-16 昌宏 黒田 Low molecular weight plant composition
JP2955126B2 (en) * 1992-06-22 1999-10-04 笑代 丹羽 Pharmaceutical oleaginous preparation, food oleaginous preparation and production method thereof
US6015913A (en) * 1996-09-06 2000-01-18 Mars, Incorporated Method for producing fat and/or solids from cocoa beans

Also Published As

Publication number Publication date
NL1019705C2 (en) 2002-03-26
GB9920710D0 (en) 1999-11-03
GB9921387D0 (en) 1999-11-10
SE0100195L (en) 2001-01-24
DE19944695A1 (en) 2000-03-30
SE9903307D0 (en) 1999-09-16
NO994463D0 (en) 1999-09-15
FR2788697A1 (en) 2000-07-28
ITTO990784A1 (en) 2001-03-14
ID23150A (en) 2000-03-23
IS5183A (en) 2000-03-17
SE9903307L (en) 2000-03-18
BE1012725A5 (en) 2001-02-06
SG76631A1 (en) 2000-11-21
GB2341800A (en) 2000-03-29
NL1013049A1 (en) 2000-03-21
IL131722A0 (en) 2001-03-19
NL1013049C2 (en) 2002-01-11
JP2000159682A (en) 2000-06-13
ITTO990784A0 (en) 1999-09-14
ES2155802A1 (en) 2001-05-16
ES2155802B1 (en) 2001-12-01
FR2783426A1 (en) 2000-03-24
NL1019705A1 (en) 2002-01-29
CA2282234A1 (en) 2000-03-17
SE0100195D0 (en) 2001-01-24
CN1255376A (en) 2000-06-07
DK199901235A (en) 2000-03-18
KR20000023206A (en) 2000-04-25
AU4486299A (en) 2000-03-30
IT1307267B1 (en) 2001-10-30

Similar Documents

Publication Publication Date Title
NO994463L (en) Antitumor activity enhancement method of unprocessed natural remedies, composition containing unprocessed herbal enhancement antitumor activity, evaluation of method of antitumor efficacy in treatment with unprocessed herbal medicine
Blom et al. Acupuncture treatment of patients with radiation-induced xerostomia
Vetulani et al. Action of various antidepressant treatments reduces reactivity of noradrenergic cyclic AMP-generating system in limbic forebrain
Malhotra et al. Nicotine and periodontal tissues
Ross Vitamin B12 assay in body fluids
ATE319457T1 (en) TREATMENT OF IATROGENIC AND AGE-RELATED HYPERTENSION WITH VITAMIN B6 DERIVATIVES, AND PHARMACEUTICAL COMPOSITIONS USABLE THEREFOR
NO20024586D0 (en) Method and preparations to prevent hormone-induced side effects
CA2301057A1 (en) A method of administering liposomal encapsulated taxane
NO973059L (en) Hydroxylamine Derivatives Useful for Increasing Molecular Chaperone Production, and Preparation thereof
NO20003051L (en) Method of administration of AspB28 human insulin
YU47899B (en) PROCEDURE FOR OBTAINING PREPARATIONS PREVENTING THE TRANSMISSION OF SEXUAL DISEASES AND THE TAMPONS CONTAINING IT
HUP0000057A2 (en) Photochemotherapeutic compositions
SE9404196D0 (en) New antithrombotic formulation
El‐Wakeel et al. Efficacy and tolerability of sildenafil/l‐arginine combination relative to sildenafil alone in patients with organic erectile dysfunction
NO20006604L (en) Methods and transdermal compositions for pain relief
WO2002040702A3 (en) Methods for the treatment of cancer and other diseases and methods of developing the same
EP0346297A1 (en) A preparation for topical use in the therapeutic treatment of impotentia coeundi
Hasselgren et al. Optimization of acid suppression for patients with peptic ulcer bleeding: an intragastric pH-metry study with omeprazole
KR100567717B1 (en) Nutritional Supplement Containing Alpha-glucosidase and Alpha-amylase Inhibitors
Kakkar et al. Prevention of venous thromboembolism in cancer using low-molecular-weight heparins
NO931886L (en) USE OF AICA RIBOCID COMPOUNDS FOR TREATMENT / PREVENTION OF TISSUE DAMAGES CAUSED BY REDUCED BLOOD FLOOD
DE60232244D1 (en) PROOF AND TREATMENT OF PROSTATE CANCER
Harris et al. Treating Helicobacter pylori--the best is yet to come?
US5904926A (en) Weight loss compound and method of using
Metin et al. Does lidocaine ointment addition increase fluoxetine efficacy in the same group of patients with premature ejaculation?

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application